Clinical significance of microcytosis in patients with primary myelofibrosis-Reference-Cited by-同舟云学术

Clinical significance of microcytosis in patients with primary myelofibrosis

Published:2014-10 Issue:10 Volume:38 Page:1212-1216
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Strati Paolo,Pemmaraju Naveen,Estrov Zeev,Cardenas-Turanzas Marylou,Pierce Sherry,Newberry Kate J.,Daver Naval,Cortes Jorge,Kantarjian Hagop,Verstovsek Srdan

Funder

MD Anderson Cancer Center

MD Anderson Cancer Center Support

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference26 articles.

1. One thousand patients with primary myelofibrosis: the mayo clinic experience;Tefferi;Mayo Clin Proc,2012

2. Primary myelofibrosis: update on definition, pathogenesis, and treatment;Abdel-Wahab;Annu Rev Med,2009

3. Microcytosis in agnogenic myeloid metaplasia: prevalence and clinical correlates;Tefferi;Leuk Res,2006

4. Recent advances in iron metabolism and related disorders;Camaschella;Intern Emerg Med,2010

5. A systematic analysis of global anemia burden from 1990 to 2010;Kassebaum;Blood,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune‐Mediated Anemia in the Dog;Schalm's Veterinary Hematology;2022-03-04

2. Disorders of red cells and platelets;Blood Cells;2021-12-31

3. Prognostic implications of low transferrin saturation in patients with primary myelofibrosis;Leukemia Research;2018-03

4. Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance;Leukemia Research;2017-06

5. Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents;Blood;2017-03-30